Major cannabis company Kaya Holdings Inc. -aka KAYS- (OTCQB: KAYS) is launching psychedelic-assisted therapy, Fifth Dimension Therapeutics (FDT) for the treatment of PTSD, addictions, eating disorders and other treatment-resistant mental health disorders.

What Happened

A senior employee of KAYS’, Bryan Arnold, enrolled in a training course to obtain an Oregon psilocybin facilitator’s license that will allow him to legally oversee the cultivation of psilocybin mushrooms and related products as well as operate up to five state-licensed psilocybin administration clinics. 

KAYS is moving into psychedelics therapy by adding experienced attorney Glenn E.J. Murphy to FDT’s board of directors in order to …

Full story available on Benzinga.com